It is worth mentioning that we also did not find any significant difference in the frequency of T cells expressing CCR7 among CD226+ and CD226−CD8+ T cells in CLL patients despite a trend towards a reduction among CD226+ T cells (Fig. S4M,N). This evidence concerns the gene CCR7 and B-cell chronic lymphocytic leukemia.